+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

South African Non-Communicable Diseases (NCD) Report 2021

  • PDF Icon

    Report

  • 150 Pages
  • March 2021
  • Region: South Africa
  • Insight Survey
  • ID: 5513251

Is Covid-19 Masking Significant Medical Advances in Non-Communicable Diseases?

The publisher’s latest South African Non-Communicable Diseases Industry Landscape Report 2021 (150 pages), provides a dynamic synthesis of medical research, examining global and South African prevalence, current treatment, new medical research and advancements for these major NCDs: Cardiovascular Diseases, Hyperlipidemia, Hypertension, Cerebrovascular Diseases, Diabetes Mellitus, Cancer, Rheumatoid Arthritis, Alzheimer’s Disease, Parkinson's Disease.

Market Research Methodology


This report is compiled using the latest available data, insights, and information from over 250 secondary and primary sources (including local and global industry associations), prominent news platforms, industry stakeholders and experts, industry websites, and the latest global and local 3rd party reports and publications, amongst others. Please note that all the sources used for the information on each slide are provided in the form of clickable links should you wish to visit the sources themselves.

Key Questions This Report Answers


The South African Non-Communicable Diseases Industry Landscape Report 2021 provides a holistic overview of the global and South African market and will help answer the following questions:


For the Global and South African Burden of Diseases Sections
  • What are the global and South African health indicators? (mortality, life expectancy, and fertility)
  • What is the global and South African burden of disease?
  • What are the global and South African top 10 causes of death?
  • What are the characteristics of the leading global and South African communicable and non-communicable causes of death?
  • What is the global and South African prevalence and mortality rate of COVID-19?

For the Non-Communicable Diseases Section:

  • What are the definitions and characteristics of each of the Non-Communicable Diseases?
  • What are the demographics and prevalence for each of the Non-Communicable Diseases?
  • What are the current treatments used for each of the Non-Communicable Diseases?
  • What are the latest new treatments, research, and medical advancements for each of the Non-Communicable Diseases?

Who Is This Report for?


This report is for people who already are actively working on this market, representatives of producers, distributors, importers, exporters, wholesalers, retailers, suppliers:

  • Industry C Level Executives
  • Directors
  • Industry Strategists
  • Marketing Professionals
  • Market Research and Intelligence Managers
  • Business Development Professionals
  • Product Developers
  • Product Marketers and Strategists
  • Product Managers
  • Project Managers
  • Suppliers
  • Traders

Categories/Products Coverage


This report covers the following categories:

  • The Non-Communicable Diseases report provides insights and advancements into Cardiovascular Diseases, Hyperlipidemia, Hypertension, Cerebrovascular Diseases, Diabetes Mellitus, Cancer, Rheumatoid Arthritis, Alzheimer’s Disease, and Parkinson's Disease.

Table of Contents

EXECUTIVE SUMMARY
  • Summary of Findings: Global Burden of Disease
  • Summary of Findings: South African Burden of Disease
  • Summary of Findings: Cardiovascular Diseases and Ischaemic Heart Disease; Hyperlipidaemia; Hypertension; Cerebrovascular Diseases; Diabetes Mellitus; Cancer; Rheumatoid Arthritis; Alzheimer’s Disease; Parkinson’s Disease
1. GLOBAL AND SOUTH AFRICAN BURDEN OF DISEASE
1.1 GLOBAL BURDEN OF DISEASE
1.1.1 Global Health Indicators: Mortality, Life Expectancy and Fertility: GLOBAL POPULATION (IN BILLION): 1970-2050*; GLOBAL POPULATION YEARLY GROWTH RATE (IN PERCENTAGE): 1970-2050* (Graphs and Table)
1.1.2 Global Burden of Disease: GLOBAL DISTRIBUTION OF DEATHS AMONGST THE THREE MAIN CAUSE GROUPS: 2017 (IN PERCENTAGE); REGIONAL DISTRIBUTION OF DEATHS AMONG THE THREE MAIN CAUSE GROUPS: 2017 (IN PERCENTAGE) (Graphs)
1.1.3 Global Top 10 Causes of Death: GLOBAL TOP 10 NUMBER OF DEATHS BY CAUSE: 2000 VS 2017 (IN MILLIONS) (Graph)
1.1.4 Global Non-Communicable Diseases: LEADING CAUSES OF NCD DEATHS: 2000 VS 2017 (IN PERCENTAGE) (Graph)
1.1.5 Global Communicable Diseases: LEADING CAUSES OF COMMUNICABLE DEATHS: 2000 VS 2017 (IN PERCENTAGE) (Graph)
1.1.6 Global Communicable Diseases: COVID-19: GLOBAL COVID-19 DEATHS: FEBRUARY 2020- FEBRUARY 2021 (IN THOUSANDS); TOTAL CUMULATIVE COVID-19 DEATHS BY REGION: 21 FEBRUARY 2021 (IN THOUSANDS); TOTAL CUMULATIVE COVID-19 DEATHS BY TOP 6 COUNTRIES: 21 FEBRUARY 2021 (IN HOUSANDS) (Graphs)
1.2 SOUTH AFRICAN BURDEN OF DISEASE
1.2.1 South African Health Indicators: Mortality, Life Expectancy and Fertility: SOUTH AFRICAN POPULATION: 1970-2050* (IN MILLIONS); SOUTH AFRICA LIFE EXPECTANCY AT BIRTH: 1970-2018 (IN YEARS); CRUDE DEATH RATE: 1970-2018 (PER 1,000 PEOPLE) (Graphs and Table)
1.2.2 South African Burden of Disease: ANNUAL NUMBER OF REGISTERED DEATHS IN SOUTH AFRICA: 2010-2017; DISTRIBUTION OF NATURAL AND NON-NATURAL CAUSES OF DEATH: 2010-2017 (IN PERCENTAGE) (Graphs)
1.2.3 South African Burden of Disease: Natural Causes of Death: TOP 10 NATURAL CAUSES OF DEATH IN SOUTH AFRICA: 2017 (IN PERCENTAGE); TOP 10 NATURAL CAUSES OF DEATH IN SOUTH AFRICA: 2015 VS 2017 (IN PERCENTAGE) (Graphs)
1.2.4 South African Burden of Disease: Main Groups of Causes of Death: DISTRIBUTION OF SOUTH AFRICAN DEATHS AMONG THE THREE MAIN GROUPS OF CAUSES OF DEATH: 2000-2017 (IN PERCENTAGE) (Graph)
1.2.5 South African Burden of Disease: Non-Communicable Diseases: TOP NON-COMMUNICABLE CAUSES OF DEATH IN SOUTH AFRICA: 2015-2017 (Graph)
1.2.6 South African Burden of Disease: Communicable Diseases: TOP COMMUNICABLE CAUSES OF DEATH IN SOUTH AFRICA: 2015-2017 (Graph)
1.2.7 Communicable Diseases: COVID-19: TOTAL DEATHS IN SOUTH AFRICA DUE TO COVID-19: MARCH 2020-FEBRUARY 2021 (Graph)
2. NON-COMMUNICABLE DISEASES
2.1 CARDIOVASCULAR DISEASES
2.1.1 Cardiovascular Diseases: Definition and Characteristics
2.1.2 Cardiovascular Diseases: Demographics and Prevalence: PREVALENCE OF CARDIOVASCULAR DISEASES IN SOUTH AFRICA: 2010-2017 (IN MILLIONS) (Graph)
2.1.3 Cardiovascular Diseases: Ischaemic Heart Disease: Definition, Characteristics, Demographics and Prevalence
2.1.4 Cardiovascular Diseases: Ischaemic Heart Disease: Demographics and Prevalence: PREVALENCE VS MORTALITY OF ISCHAEMIC HEART DISEASE IN SOUTH AFRICA: 2010-2017 (IN THOUSANDS) (Graph)
2.1.5 Cardiovascular Disease & Ischaemic Heart Disease: Current Treatments
2.1.6 Cardiovascular Diseases: New Treatments, Research and Medical Advancements
2.2 HYPERLIPIDEMIA
2.2.1 Hyperlipidemia: Definition And Characteristics
2.2.2 Hyperlipidemia: Demographics and Prevalence: ESTIMATED NUMBER OF HYPERLIPIDEMIA CASES IN SOUTH AFRICA: BY PROVINCE (2018) (IN THOUSANDS) (Graph)
2.2.3 Hyperlipidemia: Current Treatment
2.2.4 Hyperlipidemia: New Treatments, Research And Medical Advancements
2.3 HYPERTENSION
2.3.1 Hypertension: Definition and Characteristics
2.3.2 Hypertension : Demographics and Prevalence: SOUTH AFRICAN POPULATION SUFFERING FROM HYPERTENSION AS DIAGNOSED BY A MEDICAL PRACTITIONER OR NURSE, BY GENDER: 2012-2018 (IN THOUSANDS) (Graph)
2.3.3 Hypertension: Current Treatment
2.3.4 Hypertension: New Treatments, Research And Medical Advancements
2.4 CEREBROVASCULAR DISEASES
2.4.1 Cerebrovascular Diseases: Definition and Characteristics
2.4.2 Cerebrovascular Diseases: Demographics and Prevalence: STROKE PREVALENCE IN SOUTH AFRICA BY AGE: 2017 (Graph); SA PREVALENCE OF STROKE BY GENDER: 2017 (IN THOUSANDS); SA PREVALENCE OF STROKE BY TYPE: 2017 (IN PERCENTAGE) (Graphs)
2.4.4 Cerebrovascular Diseases: Ischaemic Stroke: Demographics And Prevalence
2.4.5 Cerebrovascular Diseases: Ischaemic Stroke: Current Treatment
2.4.6 Cerebrovascular Diseases: Ischaemic Stroke: New Treatments, Research And Medical Advancements
2.4.7 Cerebrovascular Diseases: Haemorrhagic Stroke: Demographics And Prevalence
2.4.8 Cerebrovascular Diseases: Haemorrhagic Stroke: Current Treatment
2.4.9 Cerebrovascular Diseases: Haemorrhagic Stroke: New Treatments, Research And Medical Advancements
2.4.10 Cerebrovascular Diseases: Carotid Stenosis: Demographics And Prevalence
2.4.11 Cerebrovascular Diseases: Carotid Stenosis: Current Treatment
2.4.12 Cerebrovascular Diseases: Carotid Stenosis: New Treatments, Research And Medical Advancements
2.4.13 Cerebrovascular Diseases: Arteriovenous Malformation: Demographics And Prevalence
2.4.14 Cerebrovascular Diseases: Arteriovenous Malformation: Current Treatment
2.4.15 Cerebrovascular Diseases: Arteriovenous Malformation: New Treatments, Research And Medical Advancements
2.5 DIABETES MELLITUS
2.5.1 Diabetes Mellitus: Definition and Characteristics
2.5.2 Diabetes Mellitus: Demographics and Prevalence: TOP 10 COUNTRIES OR TERRITORIES FOR NUMBER OF ADULTS (20-79 YEARS) WITH DIABETES: 2019 (IN MILLIONS) (Graph)
2.5.3 Diabetes Mellitus: Current Treatment
2.5.4 Diabetes Mellitus: New Treatments, Research And Medical Advancements
2.6 CANCER
2.6.1 Cancer: Definition and Characteristics
2.6.2 Cancer: Demographics and Prevalence: ESTIMATED NUMBER OF INCIDENT CASES AND DEATHS BY CANCER TYPE IN SOUTH AFRICA: MALES (2018); ESTIMATED NUMBER OF INCIDENT CASES AND DEATHS BY CANCER TYPE IN SOUTH AFRICA: FEMALES (2018) (Graphs)
2.6.3 Cancer: Current Treatments
2.6.4 Cancer: Breast Cancer: Definition and Characteristics
2.6.5 Cancer: Breast Cancer: Demographics and Prevalence
2.6.6 Cancer: Breast Cancer: Current Treatments
2.6.7 Cancer: Breast Cancer: New Treatments, Research and Medical Advancements
2.6.8 Cancer: Prostate Cancer: Definition and Characteristics
2.6.9 Cancer: Prostate Cancer: Demographics and Prevalence
2.6.10 Cancer: Prostate Cancer: Current Treatments
2.6.11 Cancer: Prostate Cancer: New Treatments, Research and Medical Advancements
2.6.12 Cancer: Lung Cancer: Definition and Characteristics
2.6.13 Cancer: Lung Cancer: Demographics and Prevalence
2.6.14 Cancer: Lung Cancer: Current Treatments
2.6.15 Cancer: Lung Cancer: New Treatments, Research and Medical Advancements
2.6.16 Cancer: Colorectal Cancer: Definition and Characteristics
2.6.17 Cancer: Colorectal Cancer: Demographics and Prevalence
2.6.18 Cancer: Colorectal Cancer: Current Treatments
2.6.19 Cancer: Colorectal Cancer: New Treatments, Research and Medical Advancements
2.7 RHEUMATOID ARTHRITIS
2.7.1 Rheumatoid Arthritis: Definition and Characteristics
2.7.2 Rheumatoid Arthritis: Demographics and Prevalence: PREVALENCE OF RHEUMATOID ARTHRITIS IN SOUTH AFRICA (Graph)
2.7.3 Rheumatoid Arthritis: Current Treatments
2.7.4 Rheumatoid Arthritis: New Treatments, Research and Medical Advancements
2.8 ALZHEIMER’S DISEASE
2.8.1 Alzheimer's Disease: Definition and Characteristics
2.8.2 Alzheimer’s Disease: Demographics and Prevalence: PREVALENCE VS. MORTALITY OF ALZHEIMER’S AND OTHER DEMENTIAS IN SOUTH AFRICA: 2010-2017 (Graph)
2.8.3 Alzheimer’s Disease: Current Treatments
2.8.4 Alzheimer’s Disease: New Treatments, Research and Medical Advancements
2.9 PARKINSON'S DISEASE
2.9.1 Parkinson's Disease: Definition And Characteristics
2.9.2 Parkinson's Disease: Demographics and Prevalence: PREVALENCE OF PARKINSON’S DISEASES IN SOUTH AFRICA: 2007 vs 2017 (Graph)
2.9.3 Parkinson's Disease: Current Treatment
2.9.4 Parkinson's Disease: New Treatments, Research And Medical Advancements

Samples

Loading
LOADING...

Executive Summary

Although the COVID-19 pandemic continues to dominate local and global discourse in terms of research and treatment, non-communicable diseases continue to have a significant negative impact on global health. Major Non-Communicable Diseases, such as Cardiovascular Disease, Cancers, and Diabetes Mellitus continue to have a significant impact on the global population, with associated rises in terms of prevalence and mortality rates.

Continuing global medical research and advancements are being conducted in terms of the major non-communicable diseases. These advances are being made across all of the major Non-Communicable Diseases affecting South Africa, including the likes of Diabetes Mellitus, Cerebrovascular Disease, and Cancers.